ABSTRACT:
Inbred CBA/H mice are susceptible to radiation-induced acute myeloid leukaemia (r-AML) and C57BL/6 mice are resistant. A genome-wide screen for linkage between genotype and phenotype (r -AML) of 67 affected (CBA/H x C57BL/6)F1 x CBA/H backcross mice has revealed at least two suggestive loci which contribute to the overall lifetime risk of r-AML. Neither is necessary or sufficient for r-AML, but is the net effect of both susceptibility (distal chromosome 1) and resistance (chromosome 6) loci. An excess of chromosome 6 aberrations in mouse r-AML and bone marrow cells up to 6 months post irradiation in vivo suggests the locus confers a proliferative advantage during the leukaemogenic process. The Stem Cell Frequency Regulator 1 (Scfr1) locus maps to distal chromosome 1 and determines the frequency of haemopoietic stem cells (HSC) in inbred mice suggesting that target size may be one factor in determining the relative susceptibility of inbred mice to r-AML.
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Introduction:
Cancer is the result of the accumulation of genetic lesions (mutations) in a single cell over time. The lifetime relative risk of cancer therefore increases with age and is determined by the mutation rate, the number of genetic lesions required for malignant transformation, the number of target cells and intercurrent mortality. Exposure to a carcinogen and/or the inactivation of gene(s) involved in maintaining genetic stability increases the mutation rate and the probability of malignant transformation. There is also a genetic component that determines an individual's relative susceptibility to de novo and/or induced cancer, and although this is exemplified in the germline transmission of rare highly penetrant alleles in familial cancer predisposition syndromes, there is increasing evidence that a high proportion of cancers arise in a susceptible sub-population that carry low penetrance gene(s) [1] [2] [3] .
Studies of Japanese atomic bomb survivors and radiotherapy and/or chemotherapy patients have shown that the main long-term health consequence of exposure is acute myeloid leukaemia (AML) and myelodysplasia (MDS). Radiation-and therapyrelated acute myeloid leukaemias (r-AML and t-AML) are clonal malignancies that arise in most cases from a multipotent haemopoietic stem cell (HSC) and commonly exhibit allelic loss (5q-or monosomy 7) and 10-15% of newly diagnosed cases of 5qor monosomy 7 AML/MDS arise in patients with a history of chemotherapy and/or radiotherapy [4] [5] [6] [7] [8] . The extensive use of combination chemotherapy/radiotherapy and/or autologous stem cell transplantation has increased long-term cancer survival, but this has resulted in a 1.5%-24% cumulative risk of secondary t-AML up to 10 years after treatment depending on the primary cancer and therapy 5, [7] [8] [9] [10] . Efforts to elucidate the genetic factors that modulate susceptibility to therapy-related AML have concentrated For personal use only. on August 31, 2017. by guest www.bloodjournal.org From on enzymes involved in carcinogen detoxification, and polymorphic variations in the genes encoding NAD(P)H:quinone oxidoreductase, cytochrome P450 3A4, epoxide hydrolase and glutathione S-transferase found to be associated with susceptibility to induced AML 11-15 . r-AML in inbred CBA/H mice is widely considered the most appropriate mouse model of human r-AML. Mouse r-AMLs arise after a long latency (mean latency 480 days post irradiation) indicating that malignant transformation of the target HSC is a multi-stage process and there is a very low (<0.1%) incidence of de novo AML in control CBA/H mice 16, 17 . A curvilinear radiation dose response curve in mouse and man is composed of an initial increase in AML risk according to (dose) 2 , followed by a decrease at higher doses 6, 16 , and is presumably the net result of two opposing dosedependent processes -mutation induction and cell death. In contrast inbred C57BL/6 mice are susceptible to radiation-induced thymic lymphoma, a thymus-dependent T cell malignancy that has no human counterpart 18 , and C57BL/6 mice can therefore be considered to be resistant to r-AML.
The differences in susceptibility to r-AML in the CBA/H and C57BL/6 inbred mouse strains can be exploited in genetic linkage analyses to map r-AML-susceptibility or resistance loci as the first step in the identification of the gene(s) involved. The lifetime incidence of r-AML in 3 Gy X-irradiated CBA/H mice is ~20%, but the incidence of r-AML in 3 Gy X-irradiated (CBA/H x C57BL/6)F1 and F1 backcross and F1 intercross mice is ~7% 16, 17 . r-AML susceptibility is therefore a complex polygenic and partially dominant mouse genetic trait and the risk following exposure is dependent on genetic background. We have therefore carried out a genome wide were taken for microscopic analyses, and tail, leukaemic spleen and kidney snap frozen. DNA was prepared from control (tail and/or kidney) and leukaemic spleen essentially as described 17, 19 .
Leukaemia diagnosis:
Myeloid leukaemias were initially diagnosed by leukaemic blood cell morphology, and leukaemic spleen then further analysed for immunoglobulin heavy chain (IgH) gene rearrangements and for expression of lineage-specific/restricted markers to identify r-AML and early pre-B lympho-myeloid (L-ML) leukaemias 17, 19 .
Genome wide screen for linkage:
Microsatellite primer sequences were from the Whitehead Institute 20 , and genetic positions from the 2000 Chromosome Committee Reports (Jackson Laboratory 21 ).
microsatellite markers across the 19 mouse autosomes were screened for
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From informative polymorphisms in the inbred CBA/H and C57BL/6 mice. 138 were identified to give a genome wide screen at ~20 cM intervals. Statistical significance of excess heterozygosity or homozygosity at individual microsatellite markers in the affected mice was evaluated using the 2 test of homogeneity, and compared to unaffected mice using the 2 test of independence 22 . Relative Risk (RR) was estimated essentially as described 23 .
RESULTS:

Leukaemia incidence in backcross mice:
The lifetime incidence of r-AML in 3 Gy X-irradiated CBA/H mice is ~20% whereas it is undetectable in X-irradiated C57BL/6 mice [16] [17] [18] . We have previously shown that there is no statistically significant difference (p = 0.3) in the proportions of mice with r-AML in irradiated (CBA/H x C57BL/6)F1, F1 backcross and F1 intercross mice (~7% lifetime incidence), but they all differ significantly (p = 0.0000013) from the r-AML incidence in the parental CBA/H strain 17 . To further elucidate the complex genetics underlying r-AML susceptibility in CBA/H mice, 1087 (CBA/H x C57BL/6)F1 x CBA/H mice (F1 x CBA/H) were exposed to 3 Gy X-rays and causes of death determined over their lifetime. 67 r-AMLs were diagnosed.
Genetic linkage analysis:
58-67 affected mice were genotyped in a genome wide screen of the 19 autosomes at <22 cM intervals using polymorphic chromosome specific microsatellite markers (Table 1) . The sex chromosomes were not analysed as susceptibility to r-AML is not sexlinked 17 . In the first instance, excess homozygosity or heterozygosity was estimated using the 2 test of homogeneity, and genetic markers that gave a 2 value of < 1.0 excluded. Genetic markers that gave a 2 value of > 1.0, were examined in further detail by genotyping all affected mice at the marker and at additional markers on either side. As illustrated in Table 1 , linkage between genotype and phenotype was observed with >99.9% point-wise probability on chromosomes 1 (excess homozygosity) and 6 (excess heterozygosity), and weaker linkage (95-99% probability) observed on chromosomes 4 (excess heterozygosity), 2 and 13 (excess homozygosity). However, only the chromosome 1 and 6 loci meet the criterion for suggestive linkage in a backcross analysis 24 .
288-357 mice of the 1020 irradiated F1 x CBA/H cohort that died of other causes (DOC) were also genotyped at the chromosomal intervals of interest to exclude segregation distortion and to test for the enrichment of specific genotypes in the affected mice using the 2 test of independence. As illustrated in Table 2 , a comparison of the affected and unaffected (DOC) mice reveals >99% confidence of linkage on chromosomes 1 (D1Mit150) and 6 (D6Mit384). The excess homozygosity detected on chromosome 2 (D2Mit237) in the affected mice was not significantly different to the D2Mit237 genotype of 272 unaffected mice (p = 0.28) so linkage to proximal chromosome 2 is excluded (data not shown). Comparison of the affected and unaffected mice using the 2 test of independence indicates that linkage at chromosomes 4 (D4Mit292; p = 0.021) and 13 (D13Mit248; p = 0.043) cannot be excluded. Given the weak penetrance of r-AML (~7% lifetime incidence) in the F1 and F1xCBA/H backcross mice, and the relatively low numbers of affected mice analysed, the statistical significance achieved is remarkable, with minimum p values occurring at D1Mit150 and D6Mit384 ( Table 2) .
Neither locus is essential for r-AML induction in the backcross mice. For example, compared to the 67 affected F1xCBA/H mice, the relative risk (RR) of r-AML in the F1xCBA/H mice that are homozygous at D1Mit150 on chromosome 1 is 2.17 (p = 0.0072), and the RR for excess heterozygosity on chromosome 6 is 2.75 (p = 0.00046). To determine whether each locus contributes additively to r-AML risk, the four genotype combinations for the most informative loci on chromosomes 1 (D1Mit150; 1 hom or 1 het ) and 6 (D6Mit384; 6 hom or 6 het ) were assessed in the affected mice and 322 mice that died of other causes. As illustrated in Table 3 ,
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Genotype of affected vs unaffected (DOC) mice at chromosomes 1 (D1Mit150, 1 hom and 1 het ) and 6 (D6Mit384; 6 hom and 6 het ).
the 2 test of homogeneity reveals no statistically significant deviation from the 1:1:1:1 ratio expected for the four genotype combinations in unaffected DOC mice (p = 0.57). In contrast, the affected mice do show a statistically significant deviation from the expected (p = 0.00013). The 2 test of independence reveals a statistically significant difference of the relative proportions of the four genotypes in the affected mice compared to the unaffected mice ( 2 = 18.64; df = 3; p = 0.000325), and RR estimates indicate that this statistical significance is driven by the enrichment of the most favoured 1 hom 6 het genotype (RR = 2.99) and depletion of the least favoured 1 het 6 hom genotype (RR = 0.27) in the affected mice (Table 3) .
During the course of these studies, 54 early pre-B mixed lineage lympho-myeloid leukaemias (L-ML) were diagnosed 19 in the irradiated backcross mice. The r-AML and L-ML loss of heterozygosity profiles on chromosomes 2 and 4 differ 19 , suggesting that they represent two distinct haemopoietic malignancies, and mice (Tables 2 and 3 ). However, further evidence to support the proposition that two distinct leukaemogenic processes are involved can be inferred when the four genotype combinations for the most informative loci on chromosomes 1 (D1Mit150; 1 hom or 1 het ) and 6 (D6Mit384; 6 hom or 6 het ) were compared in r-AML and L-ML affected mice. As shown in Table 4 , Table 4 :
Genotype of r-AML and L-ML affected mice at chromosomes 1 (D1Mit150, 1 hom and 1 het ) and 6 (D6Mit384; 6 hom and 6 het ).
the 2 test of homogeneity reveals no statistically significant deviation from the 1:1:1:1 ratio expected for the four genotype combinations in L-ML affected mice (p = 0.28), and the 2 test of independence reveals a statistically significant difference of the relative proportions of the four genotypes in the r-AML and L-ML affected mice ( 2 = 14.6; df = 3; p = 0.0022). RR estimates indicate that this statistical significance is again driven by the enrichment of the most favoured r-AML 1 hom 6 het genotype (RR = 3.01) and depletion of the least favoured r-AML 1 het 6 hom genotype (RR = 0.176) in 3 .01 (p = 0.007) 0.176 (p = 0.0015)
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As the lifetime incidence of r-AML in the F1 x CBA/H mice as a whole is 6.7%, and the F1 x CBA/H subpopulation with the most favoured 1 hom 6 het genotype has a 2.99 RR, the incidence of r-AML in the hybrid 1 hom 6 het genotype F1 x CBA/H mouse subpopulation is very similar to the 20% lifetime r-AML incidence in the parental inbred CBA/H strain 16, 17 .
DISCUSSION:
The r-AML-susceptible CBA/H and resistant C57BL/6 inbred mouse strains have been exploited in a genome wide genetic linkage analysis of (CBA/H x C57BL/6)F1 x CBA/H backcross mice to identify at least two suggestive loci (chromosomes 1 and 6) each of which make a modest ~2-fold contribution to the relative risk of r-AML in the (CBA/H x C57BL/6)FI x CBA/H backcross mice following exposure to 3 Gy X-rays.
Together, a relative risk of 3 for both genotypes accounts for the difference in the lifetime r-AML incidence in irradiated F1 x CBA/H backcross cohort as a whole (6.7% incidence) and in the irradiated parental inbred CBA/H mouse strain (20% incidence).
Although the results of the ~1500 cM genetic linkage analysis has focused attention on two suggestive ~7 cM chromosomal intervals, it is self-evident that neither is necessary nor sufficient for r-AML and other low penetrance genes are clearly involved. The statistical power of the current study of (CBA/H x C57BL/6)F1 x CBA/H backcross mice is constrained by the low (~7%) lifetime incidence of r-AML in the 1037 X-irradiated mice analysed. For example, there is weak evidence that loci on chromosomes 4 and 13 may also be involved (Table 1) , but the statistical power is insufficient to satisfy accepted criterion for suggestive linkage 24 . Nevertheless, the intervals on mouse chromosomes 1, 6 and 13 defined by the minimum p values in the 2 test of homogeneity (Tables 1, 2 and data not shown) are syntenic with human chromosomes 1q41-42, 7p21 and 5q23-35 respectively 21 , an intriguing observation given that induced AML in man commonly involves monosomy 7 and/or 5q-4,5 .
Furthermore, as there is no statistically significant difference in the incidence of r- It is highly likely that the size of the stem cell compartment is regulated by multiple genes in addition to Scfr1, and differences in cell survival/radiosensitivity following exposure to 3 Gy X-rays a further potential factor in determining effective target size in the subsequent multistage leukaemogenic process. Inter-individual variation in bone marrow CD34 + stem-and CFU-GM progenitor cell numbers has been reported in man [30] [31] [32] [33] , and whilst some of the variation observed may be due to technical difficulties in the assays, and the assays may not necessarily accurately reflect target LT-HSC numbers, the magnitude of the inter-individual variation observed suggests that target size does vary within the human population.
The excess heterozygosity detected on chromosome 6 ( Table 2) suggests the presence of a CBA/H r-AML resistance locus. However, loss of heterozygosity (LOH) studies did not detect allelic loss on chromosome 6 in r-AMLs 34 (and data not shown), indicating that the locus does not appear to be subject to the inactivation processes normally associated with tumour suppressor genes. Over 100 r-AMLs that arose in irradiated inbred CBA, C3H, RFM and B6C3F1 genetic backgrounds have been analysed for clonal chromosomal abnormalities by conventional G-banding or FISH [35] [36] [37] [38] [39] . As summarised in Table 1 , allelic loss (terminal or interstitial deletions) on chromosome 2 is observed in >95% r-AMLs, aberrations on chromosome 6 represent the next most frequent clonal aberration (33.5%) followed by chromosome 15 (22%).
Significantly trisomy 6 (15%) is observed at a >2 fold higher frequency than trisomy 15 (7.1%) or 1 (6%) and at a >3.5 fold higher incidence than trisomy of any of the other 15 autosomes. Chromosomal abnormalities involving chromosome 15, and trisomy in particular, are frequently observed in mouse radiation-induced thymic lymphomas and have been implicated in tumour progression 40 . In addition to the relative excess of chromosome 6 aberrations in the r-AMLs, an excess of CBA/H mouse bone marrow cells carrying aberrations of chromosomes 2 or 6 have also been reported in mice up to 6 months after exposure to 3 Gy X-rays 41 , suggesting that these aberrations confer a proliferative advantage in vivo. This is consistent with the genetic analyses that indicate that whilst excess heterozygosity on chromosome 6 is neither necessary nor sufficient for radiation leukaemogenesis, it does increase the RR of r-AML.
Ionising radiation induces genetic instability in the clonal descendents of a single irradiated cell that persists for many cell generations in vitro and in vivo, so exposure For personal use only. on August 31, 2017. by guest www.bloodjournal.org From potentially results in an elevated mutation rate 42, 43 . Radiation-induced genetic instability is induced at a higher efficiency in the clonal descendents of an irradiated short-term repopulating HSC (ST-HSC) from the r-AML susceptible CBA/H mouse than in ST-HSC from the r-AML-resistant C57BL/6 mouse, and appears to be a recessive CBA/H genetic trait as it is induced at the lower efficiency in the (CBA/H x C57BL/6)F1 hybrid 44 . A modest increase in mutation rate due to a genetically determined susceptibility to radiation-induced genetic instability could result in a modest increase in the risk of r-AML without being absolutely necessary for the radiation-leukaemogenic process. Significantly, a genetic component to radiationinduced genetic instability has also been observed in human ST-HSC 45 , and ongoing chromosomal instability detected in mouse and human r-AML 36, 46 .
The genetic data presented here is further supportive 17 evidence that r-AML susceptibility in the CBA/H mouse model is a complex polygenic trait involving low penetrance resistance and susceptibility loci. As this is consistent with the proposal that most cancers/leukaemias arise in a susceptible human sub-population 3 , the CBA/H mouse model may be more relevant to human induced AML than might have been expected. Furthermore, the co-localisation of the suggestive chromosome 1 r-AML susceptibility locus and Scfr1 raises the possibility that in addition to the number of genetic lesions required for malignant transformation and the mutation rate, target cell numbers may be part of the equation defining target size in oncogenesis. This is a provocative but testable hypothesis, and has potential implications in our understanding of low penetrance genetic risk factors.
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